FC26: Oral Psoriasis Therapies: A Brighter Horizon: An Online Activity

Section cover
Released on
November 20, 2026
Earn up to
0.75 AMA PRA Category 1 Credit(s)™

Oral therapies are providing more ways to harmonize psoriasis treatment goals and patient preferences. Walk through the clinical evidence with expert faculty from the 2026 Fall Clinical Dermatology Conference® and gather insights into guiding your own patients through this broadening therapeutic landscape.

“Sometimes the worst thing we can do for patients is give them too many options because I think it makes the decision very overwhelming. I learned very early on that, rather than listing out all the options, I'll give them buckets. ‘We have topicals, we have phototherapy, we have orals, we have injectables, but I think these are probably the few options that are best for you.’… I think now with some of our oral agents, it truly is a shared experience. I can say, ‘You know, we have good drugs, both oral and injectable. Which one do you think would be best for your lifestyle?’” – Tina Bhutani, MD, MAS

FC26: Oral Psoriasis Therapies: A Brighter Horizon: An Online Activity

This activity is supported by an educational grant from Johnson & Johnson.